Trwa ładowanie...
Notowania
SOPHARMA: strona spółki
23.09.2021, 16:02

SPH Notification under Art. 111 para. 6 of LPOS for repurchase of shares

“Sopharma” AD (the Company) notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para. 6 of LPOS and in connection with a decision of the General Meeting of the company held on February 23, 2018 and a decision of the Board of Directors of September 23, 2021, “Sopharma” AD notifies that the company intends to buy its own shares in the restriction under Art. 111 para. 5 of LPOS, as follows:

Załączniki

Inne komunikaty

DataTytułKursZmiana
2024-09-19
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
12,65
0,00
2024-09-18
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
13,00
-2,69
2024-09-17
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
13,00
0,00
2024-09-16
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
13,00
0,00
2024-09-13
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
13,20
-4,17
2024-09-12
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
14,40
-8,33
2024-09-11
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
14,40
0,00
2024-09-10
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
14,40
0,00
2024-09-10
SPH Notification from Rositsa Doneva in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
14,40
0,00
2024-09-09
SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
14,40
0,00